Literature DB >> 21358199

Combined effects of smoking and hypercholesterolemia on the risk of stroke and coronary heart disease in Japanese: the Hisayama study.

Jun Hata1, Yasufumi Doi, Toshiharu Ninomiya, Masayo Fukuhara, Fumie Ikeda, Naoko Mukai, Yoichiro Hirakawa, Takanari Kitazono, Yutaka Kiyohara.   

Abstract

BACKGROUND: Cigarette smoking is an established risk factor for stroke and coronary heart disease (CHD) in Western countries. However, it is uncertain whether or not smoking raises the risk of stroke in Japanese. We examined the influence of smoking on the development of stroke and CHD and the effects of interactions between smoking and hypercholesterolemia on these outcomes in a general Japanese population.
METHODS: A total of 2,421 community-dwelling Japanese individuals, aged 40-79 years, with no history of cardiovascular disease, were followed up for 14 years.
RESULTS: During the follow-up, 194 total stroke and 112 CHD events occurred. Compared with never smokers, the multivariate-adjusted hazard ratios for the occurrence of total stroke were 1.53 (95% confidence interval = 0.90-2.61) in former smokers, 1.90 (1.18-3.06) in current light smokers (<20 cigarettes/day) and 2.01 (1.11-3.65) in current heavy smokers (≥ 20 cigarettes/day). The multivariate-adjusted hazard ratios for the development of CHD were 1.10 (0.56-2.15), 1.88 (1.02-3.47) and 2.31 (1.17-4.57), respectively. In regard to stroke subtypes, current smoking was an independently significant risk factor for ischemic stroke and subarachnoid hemorrhage. Furthermore, the combination of smoking and hypercholesterolemia synergistically increased the risks of total stroke and CHD (all p for interaction <0.05).
CONCLUSION: Our findings suggest that smoking raises the risks of ischemic stroke, subarachnoid hemorrhage and CHD occurrence in the Japanese population, and that this effect is strengthened by hypercholesterolemia.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21358199     DOI: 10.1159/000324392

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  12 in total

1.  Relationships of LDLR genetic polymorphisms with cerebral infarction: a meta-analysis.

Authors:  Hai-Cheng Yan; Wei Wang; Chang-Wu Dou; Fu-Ming Tian; Song-Tao Qi
Journal:  Mol Biol Rep       Date:  2014-03-05       Impact factor: 2.316

2.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

3.  The effectiveness of IDF and ATP-III in identifying metabolic syndrome and the usefulness of these tools for health-promotion in older Taiwanese.

Authors:  M M Chen; A C Tsai
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

4.  Long-term prognosis in patients with clipped unruptured cerebral aneurysms--increased cerebrovascular events in patients with surgically treated unruptured aneurysms.

Authors:  Masaaki Hokari; Satoshi Kuroda; Naoki Nakayama; Kiyohiro Houkin; Tatsuya Ishikawa; Hiroyasu Kamiyama
Journal:  Neurosurg Rev       Date:  2013-04-19       Impact factor: 3.042

5.  Correlates of former smoking in patients with cerebrovascular disease: a cross-sectional study.

Authors:  Rojiemiahd K Edjoc; Robert D Reid; Mukul Sharma; Louise Balfour; Michael Procino
Journal:  BMJ Open       Date:  2015-01-21       Impact factor: 2.692

6.  Differences in risk factors for 3 types of stroke: UK prospective study and meta-analyses.

Authors:  Alison J Price; F Lucy Wright; Jane Green; Angela Balkwill; Sau Wan Kan; TienYu Owen Yang; Sarah Floud; Mary E Kroll; Rachel Simpson; Cathie L M Sudlow; Valerie Beral; Gillian K Reeves
Journal:  Neurology       Date:  2018-01-10       Impact factor: 9.910

Review 7.  Meta-Analysis for Clinical Evaluation of Xingnaojing Injection for the Treatment of Cerebral Infarction.

Authors:  Xiao Ma; Yu X Yang; Nian Chen; Qian Xie; Tao Wang; Xuan He; Jian Wang
Journal:  Front Pharmacol       Date:  2017-08-29       Impact factor: 5.810

8.  Synergistic and Non-synergistic Associations for Cigarette Smoking and Non-tobacco Risk Factors for Cardiovascular Disease Incidence in the Atherosclerosis Risk In Communities (ARIC) Study.

Authors:  Jay H Lubin; David Couper; Pamela L Lutsey; Hiroshi Yatsuya
Journal:  Nicotine Tob Res       Date:  2017-07-01       Impact factor: 4.244

9.  A prospective study of tobacco smoking and mortality in Bangladesh.

Authors:  Fen Wu; Yu Chen; Faruque Parvez; Stephanie Segers; Maria Argos; Tariqul Islam; Alauddin Ahmed; Muhammad Rakibuz-Zaman; Rabiul Hasan; Golam Sarwar; Habibul Ahsan
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

10.  Forced Expiratory Volume in the First Second and Aldosterone as Mediators of Smoking Effect on Stroke in African Americans: The Jackson Heart Study.

Authors:  Wei Wang; Gui Shen; Eyal Shahar; Aurelian Bidulescu; W Taylor Kimberly; Kevin N Sheth; Brenda W Campbell; Steven Horbal; Adolfo Correa; Michael E Griswold
Journal:  J Am Heart Assoc       Date:  2016-01-27       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.